findmyKOL
Clinical trialNCT03394196TerminatedInterventional

RESIST-2: 2nd-line ART for HIV-2 Infection

SponsorUniversity of WashingtonEnrollment152HIV-2 Infection
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Prospective, longitudinal, open label, HIV-2 viral load and antiretroviral resistance informed 2nd-line ARV implementation study.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Senegal
  • Centre de Sante de Ziguinchor

    Ziguinchor, Casamance, Senegal

  • Clinique Des Maladies Infectieuses Ibrahima Diop Mar/crcf, Centre Hospitalier Universitaire de Fann

    Dakar, Senegal

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

2nd line ART
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Jul 2018
Primary completion
31 May 2020
Completion
31 May 2020
Last update posted
25 Jan 2021
Registered enrollment
152
Registry id
NCT03394196
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.